查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1592002

體外診斷設備市場：按產品、最終用戶分類 - 2025-2030 年全球預測

In-Vitro Diagnostics Instrument Market by Product (Clinical Microbiology, Hematology, Hemostasis), End User (Academic & Research Institutes, Homecare, Hospitals & Diagnostic Laboratories) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年體外診斷設備市場價值為241.8億美元，預計2024年將達到262.3億美元，複合年成長率為8.58%，到2030年將達到430.4億美元。

體外診斷 (IVD) 設備市場包括實驗室中使用的各種設備，用於對血液、尿液和組織等樣本進行測試，以幫助診斷疾病、監測治療和預防健康狀況。對 IVD 設備的需求源於其提供快速、準確的測試結果的能力，這對於有效的患者管理和降低醫療成本至關重要。研究應用包括臨床化學、免疫化學、分子診斷和血液學，最終用途包括醫院、學術機構、診斷中心和實驗室。關鍵的成長要素包括慢性病盛行率上升、老年人口不斷成長、技術進步以及對個人化醫療的需求。機會比比皆是，包括開發就地檢驗設備、擴大其在居家醫療環境中的使用，以及整合人工智慧以改善診斷。抓住這些機會的建議包括投資創新解決方案的研發以及建立策略夥伴關係以擴大市場。然而，市場成長面臨嚴格的監管要求、高昂的開發成本和競爭壓力等挑戰，這可能會限制中小企業的進入並延長新產品的上市時間。需要技術創新的領域包括開發具有成本效益、快速且可攜式的診斷工具以及開發分子診斷技術以提高準確性。該市場的特點是競爭格局充滿活力，主要企業努力實現技術進步和新產品推出，以獲得競爭優勢。隨著產業轉向數位化和互連解決方案，診斷中對資料隱私、互通性和網路安全的重視變得越來越重要。為了在這個不斷發展的市場中取得成功，公司應該專注於提高產品可靠性、減少測試時間以及從傳統環境中擴展應用程式，以滿足廣泛的醫療和消費者需求。

主要市場統計
基準年[2023] 241.8億美元
預測年份 [2024] 262.3億美元
預測年份 [2030] 430.4億美元
複合年成長率（%） 8.58%

市場動態：快速發展的體外診斷設備市場的關鍵市場洞察

供需的動態交互作用正在改變體外診斷設備市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 老年人口增加，慢性病及感染疾病率顯著
    • 在已開發地區增加全自動和 POC 設備的引進和可用性
    • 提高對疾病適應症和診斷的認知
  • 市場限制因素
    • 不利的贖回選擇
  • 市場機會
    • 有針對性的產品開發和商業化
    • 聯合研究和產品開發
  • 市場挑戰
    • 嚴格的監管要求

波特五力：駕馭體外診斷設備市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解體外診斷設備市場的外部影響

外部宏觀環境因素在塑造體外診斷設備市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解體外診斷設備市場的競爭狀況

對體外診斷設備市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣體外診斷設備市場供應商績效評估

FPNV 定位矩陣是評估體外診斷設備市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，描繪體外診斷設備市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對體外診斷設備市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 人口老化加劇以及慢性病和感染疾病的蔓延
      • 提高已開發地區全自動和 POC 設備的部署和可用性
      • 提高對疾病徵兆和診斷的認知
    • 抑制因素
      • 不利的退款選擇
    • 機會
      • 有針對性的產品開發和商業化
      • 聯合研究和產品開發
    • 任務
      • 嚴格的監管要求
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章體外診斷設備市場：依產品

  • 臨床微生物學
  • 血液學
  • 止血
  • 免疫化學
  • 分子診斷
  • 照護現場
  • 自我監測血糖值
  • 組織診斷

第7章體外診斷設備市場：依最終用戶分類

  • 學術研究所
  • 居家護理
  • 醫院和診斷實驗室

第8章 北美、南美體外診斷設備市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太地區體外診斷設備市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章 歐洲、中東、非洲體外診斷設備市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Accelerate Diagnostics, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Biomerieux SA
  • Diasorin SPA
  • F. Hoffmann-La Roche Ltd.
  • GenomeMe Inc.
  • Grifols SA
  • Hologic, Inc.
  • PerkinElmer Inc.
  • Qiagen NV
  • Siemens Healthineers
  • Sysmex Corporation
  • Thermo Fisher Scientific, Inc.
Product Code: MRR-43127F7279FB

The In-Vitro Diagnostics Instrument Market was valued at USD 24.18 billion in 2023, expected to reach USD 26.23 billion in 2024, and is projected to grow at a CAGR of 8.58%, to USD 43.04 billion by 2030.

The In-Vitro Diagnostics (IVD) Instrument market encompasses a wide range of devices used in laboratories to perform tests on samples such as blood, urine, and tissue, aiding in disease diagnosis, treatment monitoring, and health condition prevention. The necessity of IVD instruments stems from their ability to provide quick and accurate test results, crucial for effective patient management and reducing healthcare costs. Applications include clinical chemistry, immunochemistry, molecular diagnostics, and hematology, with end-use scope spanning hospitals, academic institutions, diagnostic centers, and research laboratories. Key growth influencers include the rising prevalence of chronic diseases, increasing geriatric population, advances in technology, and demand for personalized medicine. Opportunities abound in developing point-of-care testing devices, expanding use in home-care settings, and integrating artificial intelligence for improved diagnostics. Recommendations to seize these opportunities include investing in R&D for innovative solutions and forming strategic partnerships to broaden market reach. However, market growth faces challenges such as stringent regulatory requirements, high development costs, and competitive pressure, which can limit smaller players' entry and longer time-to-market for new products. Areas ripe for innovation include developing cost-effective, rapid, and portable diagnostic tools and exploring molecular diagnostic techniques for enhanced precision. The market is characterized by a dynamic and competitive landscape, with key players striving for technological advancements and newer product launches to gain competitive advantages. Emphasis on data privacy, interoperability, and cybersecurity in diagnostics is increasingly crucial as the industry shifts towards digital and interconnected solutions. To thrive in this evolving market, companies should focus on enhancing product reliability, reducing testing times, and expanding applications beyond traditional settings to suit a wider array of medical and consumer needs.

KEY MARKET STATISTICS
Base Year [2023] USD 24.18 billion
Estimated Year [2024] USD 26.23 billion
Forecast Year [2030] USD 43.04 billion
CAGR (%) 8.58%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving In-Vitro Diagnostics Instrument Market

The In-Vitro Diagnostics Instrument Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising geriatric population and significant prevalence of chronic and infectious diseases
    • Increasing adoption and availability of fully automated and POC instruments in developed regions
    • Increased awareness about disease indication & diagnostics
  • Market Restraints
    • Non-favourable reimbursement options
  • Market Opportunities
    • Targeted product development and commercialization
    • Collaborative research and product development
  • Market Challenges
    • Stringent regulatory requirements

Porter's Five Forces: A Strategic Tool for Navigating the In-Vitro Diagnostics Instrument Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the In-Vitro Diagnostics Instrument Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the In-Vitro Diagnostics Instrument Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the In-Vitro Diagnostics Instrument Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the In-Vitro Diagnostics Instrument Market

A detailed market share analysis in the In-Vitro Diagnostics Instrument Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the In-Vitro Diagnostics Instrument Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the In-Vitro Diagnostics Instrument Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the In-Vitro Diagnostics Instrument Market

A strategic analysis of the In-Vitro Diagnostics Instrument Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the In-Vitro Diagnostics Instrument Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Accelerate Diagnostics, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Biomerieux SA, Diasorin S.P.A., F. Hoffmann-La Roche Ltd., GenomeMe Inc., Grifols SA, Hologic, Inc., PerkinElmer Inc., Qiagen N.V., Siemens Healthineers, Sysmex Corporation, and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the In-Vitro Diagnostics Instrument Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Clinical Microbiology, Hematology, Hemostasis, Immunochemistry, Molecular Diagnostics, Point-of-Care, Self-Monitoring of Blood Glucose, and Tissue Diagnostics.
  • Based on End User, market is studied across Academic & Research Institutes, Homecare, and Hospitals & Diagnostic Laboratories.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising geriatric population and significant prevalence of chronic and infectious diseases
      • 5.1.1.2. Increasing adoption and availability of fully automated and POC instruments in developed regions
      • 5.1.1.3. Increased awareness about disease indication & diagnostics
    • 5.1.2. Restraints
      • 5.1.2.1. Non-favourable reimbursement options
    • 5.1.3. Opportunities
      • 5.1.3.1. Targeted product development and commercialization
      • 5.1.3.2. Collaborative research and product development
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory requirements
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. In-Vitro Diagnostics Instrument Market, by Product

  • 6.1. Introduction
  • 6.2. Clinical Microbiology
  • 6.3. Hematology
  • 6.4. Hemostasis
  • 6.5. Immunochemistry
  • 6.6. Molecular Diagnostics
  • 6.7. Point-of-Care
  • 6.8. Self-Monitoring of Blood Glucose
  • 6.9. Tissue Diagnostics

7. In-Vitro Diagnostics Instrument Market, by End User

  • 7.1. Introduction
  • 7.2. Academic & Research Institutes
  • 7.3. Homecare
  • 7.4. Hospitals & Diagnostic Laboratories

8. Americas In-Vitro Diagnostics Instrument Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific In-Vitro Diagnostics Instrument Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa In-Vitro Diagnostics Instrument Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Accelerate Diagnostics, Inc.
  • 3. Becton, Dickinson and Company
  • 4. Bio-Rad Laboratories, Inc.
  • 5. Biomerieux SA
  • 6. Diasorin S.P.A.
  • 7. F. Hoffmann-La Roche Ltd.
  • 8. GenomeMe Inc.
  • 9. Grifols SA
  • 10. Hologic, Inc.
  • 11. PerkinElmer Inc.
  • 12. Qiagen N.V.
  • 13. Siemens Healthineers
  • 14. Sysmex Corporation
  • 15. Thermo Fisher Scientific, Inc.

LIST OF FIGURES

  • FIGURE 1. IN-VITRO DIAGNOSTICS INSTRUMENT MARKET RESEARCH PROCESS
  • FIGURE 2. IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. IN-VITRO DIAGNOSTICS INSTRUMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. IN-VITRO DIAGNOSTICS INSTRUMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY CLINICAL MICROBIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY HEMOSTASIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY IMMUNOCHEMISTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY POINT-OF-CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY SELF-MONITORING OF BLOOD GLUCOSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY TISSUE DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 29. MEXICO IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 31. UNITED STATES IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. UNITED STATES IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 34. ASIA-PACIFIC IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. ASIA-PACIFIC IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. ASIA-PACIFIC IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 37. AUSTRALIA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. AUSTRALIA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. CHINA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. CHINA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 41. INDIA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. INDIA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 43. INDONESIA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. INDONESIA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. JAPAN IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. JAPAN IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. MALAYSIA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. MALAYSIA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. PHILIPPINES IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. PHILIPPINES IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 51. SINGAPORE IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. SINGAPORE IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. SOUTH KOREA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. SOUTH KOREA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. TAIWAN IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. TAIWAN IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. THAILAND IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. THAILAND IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. VIETNAM IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. VIETNAM IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 64. DENMARK IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. DENMARK IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. EGYPT IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. EGYPT IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. FINLAND IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. FINLAND IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. FRANCE IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. FRANCE IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. GERMANY IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. GERMANY IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. ISRAEL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. ISRAEL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. ITALY IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. ITALY IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. NETHERLANDS IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. NETHERLANDS IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. NIGERIA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. NIGERIA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. NORWAY IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. NORWAY IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 84. POLAND IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. POLAND IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. QATAR IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. QATAR IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. RUSSIA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. RUSSIA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. SAUDI ARABIA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. SAUDI ARABIA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH AFRICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. SOUTH AFRICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. SPAIN IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. SPAIN IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. SWEDEN IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. SWEDEN IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. SWITZERLAND IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. SWITZERLAND IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. TURKEY IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. TURKEY IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED ARAB EMIRATES IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED ARAB EMIRATES IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 104. UNITED KINGDOM IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. UNITED KINGDOM IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 107. IN-VITRO DIAGNOSTICS INSTRUMENT MARKET, FPNV POSITIONING MATRIX, 2023